(Q37167995)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490408%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

review article

1 reference

title

Systemic lupus erythematosus and cardiovascular disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490408%20AND%20SRC:MED&resulttype=core&format=json

systemic lupus erythematosus

7 January 2020

main subject

cardiovascular disease

1 reference

based on heuristic

inferred from title

0 references

author

Johan Frostegard

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490408%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

J Frostegård

series ordinal

1

1 reference

18 August 2017

publication date

1 May 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490408%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490408%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490408%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490408%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

364-367

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490408%20AND%20SRC:MED&resulttype=core&format=json

Atherosclerosis — An Inflammatory Disease

7 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0961203308089988

Innate and adaptive immunity in the pathogenesis of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308089988

Innate and acquired immunity in atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308089988

The bimodal mortality pattern of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308089988

Inflammation-mediated rheumatic diseases and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308089988

Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308089988

Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308089988

The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308089988

Large cerebral vessel occlusive disease in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308089988

Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308089988

Premature coronary-artery atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308089988

SLE, atherosclerosis and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308089988

Risk factors for cardiovascular disease in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308089988

TNF-alpha: a link between hypertriglyceridaemia and inflammation in SLE patients with cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308089988

Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308089988

Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308089988

Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308089988

Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308089988

A phase I trial of intravenously-administered recombinant tumor necrosis factor-alpha in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308089988

Role of cytokines in inducing hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308089988

Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308089988

Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308089988

Apolipoprotein A-I inhibits the production of interleukin-1beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308089988

Antibodies of IgM subclass to phosphorylcholine and oxidized LDL are protective factors for atherosclerosis in patients with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308089988

Atheroprotective natural anti-phosphorylcholine antibodies of IgM subclass are decreased in Swedish controls as compared to non-westernized individuals from New Guinea

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308089988

International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308089988

Epidemiology of the antiphospholipid antibody syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308089988

A vegan diet free of gluten improves the signs and symptoms of rheumatoid arthritis: the effects on arthritis correlate with a reduction in antibodies to food antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308089988

21 January 2018

Identifiers

DOI

10.1177/0961203308089988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490408%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference